Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Frequently asked questions
What sector does Pharming Group NV (PHARM) operate in?
Pharming Group NV belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Pharming Group NV (PHARM) current stock price?
As of the latest data, Pharming Group NV stock price is €1.02, with a previous close of €1.03. Pharming Group NV lost -€0.01 in the last trading session, representing a -1.26% loss.
What is Pharming Group NV (PHARM) current market capitalization?
Pharming Group NV market cap is approximately 718.40 million.
What is Pharming Group NV (PHARM) Earnings Per Share (EPS)?
The trailing EPS is €0.01, and the forward EPS is €0.03.
What is Pharming Group NV (PHARM) Price-to-Earnings (P/E) ratio?
Pharming Group NV current P/E ratio is 101.5, with a forward P/E of 40.28.
What is Pharming Group NV (PHARM) EBITDA?
Pharming Group NV EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 4.34 million.
Does Pharming Group NV (PHARM) pay dividends?
No. Pharming Group NV does not pay a dividend.
When is Pharming Group NV (PHARM) next earnings report?
Pharming Group NV is expected to release its next earnings report on September 30, 2026.
What is Pharming Group NV (PHARM) beta (volatility) score?
Pharming Group NV has a beta of 0.062, indicating lower volatility than the overall market.
